Kyeong Soo Kim

This inventor holds 10 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 11 EPO patents. Top assignees: Hanmi Pharm. Co., Ltd., Hanmi Science Co., Ltd.. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyeong Soo Kim. Retrieved from https://idiyas.com/inventor/kyeong-soo-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 12)

% Patents Active = 50.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 33(Granted Patents)

Company Filing History:

7 out of 148

Hanmi Pharm. Co., Ltd.

patents

3 out of 63

Hanmi Science Co., Ltd.

patents

Years Active: 2012-2018

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9931406 - Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant (2018-04-03),

2. 9731022 - Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant (2017-08-15),

3. 9549936 - Method for preparing dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide (2017-01-24),

4. 9486528 - Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof (2016-11-08),

5. 9283232 - Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same (2016-03-15),

6. 9220704 - Composite formulation comprising a tablet encapsulated in a hard capsule (2015-12-29),

7. 9161933 - Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same (2015-10-20),

8. 8673945 - Solid pharmaceutical composition comprising amlodipine and losartan (2014-03-18),

9. 8673944 - Solid pharmaceutical composition comprising amlodipine and losartan with improved stability (2014-03-18),

10. 8127516 - Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same (2012-03-06),

Title: Kyeong Soo Kim: Innovator in Pharmaceutical Composition

Introduction

Kyeong Soo Kim is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that inhibit the growth of cancer cells. With a total of 10 patents to his name, Kim's work is recognized for its innovative approach and practical applications.

Latest Patents

Among his latest patents is a pharmaceutical composition comprising an amide derivative that effectively inhibits the growth of cancer cells. This composition also includes a non-metallic salt lubricant, which enhances its storage stability without compromising quality over time. This innovative formulation represents a significant advancement in cancer treatment options.

Career Highlights

Kyeong Soo Kim has worked with prominent companies in the pharmaceutical industry, including Hanmi Pharm Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Some of his notable coworkers include Jae Hyun Park and Jong Soo Woo. Their collaborative efforts have further enriched the research and development processes in which Kim has been involved.

Conclusion

Kyeong Soo Kim's contributions to pharmaceutical innovations highlight his dedication to improving cancer treatment through effective compositions. His work continues to inspire advancements in the field, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.